Condition
Primary Biliary Cholangitis (PBC) clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Primary Biliary Cholangitis (PBC) clinical trials that are recruiting, at sites in 29 countries (most in China (5), Spain (4), Argentina (1)). By phase: Phase 3 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 29Countries
Newest Primary Biliary Cholangitis (PBC) clinical trials
All recruiting trials (9)
-
Biochemical response and health outcomes in people with primary biliary cholangitis
We will follow adults with primary biliary cholangitis who are taking ursodeoxycholic acid (UDCA) to see if their alkaline phosphatase levels after treatment predict how long they stay free of complications.
-
Fenofibrate versus UDCA for first-line treatment of primary biliary cholangitis
This study will test whether fenofibrate works better than the standard medicine UDCA for adults with newly diagnosed primary biliary cholangitis who have not been treated before.
-
Early detection of primary biliary cholangitis in people with positive AMA and normal ALP
This project will test whether clinical features, blood markers, or a liver biopsy can identify early PBC in adults (18-80) who have positive AMA but normal ALP.
-
Multimodal prehabilitation to reduce fatigue in primary biliary cholangitis
This trial will try a combined program of supervised exercise, nutritional counseling, and mindfulness to reduce fatigue in adults with primary biliary cholangitis who have moderate-to-severe fatigue.
-
Long-term outcomes of primary biliary cholangitis in China
This project will follow about 4,000 people in China with primary biliary cholangitis to see how symptoms, disease stage, and treatments affect long-term survival.
-
Registry for autoimmune and cholestatic liver diseases in Spain
This study is collecting information from patients with liver diseases in Spain to better understand these conditions and improve care for those affected.
-
Using Fenofibrate with Ursodeoxycholic Acid for Primary Biliary Cholangitis
This study is testing whether combining fenofibrate with ursodeoxycholic acid is safe and helpful for people with Primary Biliary Cholangitis who have taken part in a related study before.
-
Using Fenofibrate with Ursodeoxycholic Acid for Primary Biliary Cholangitis
This study is testing if taking fenofibrate with ursodeoxycholic acid can be safe and helpful for people with Primary Biliary Cholangitis who have already been part of a related study.
-
Long-term treatment with elafibranor for adults with primary biliary cholangitis
This study is testing if the medication elafibranor can help adults with primary biliary cholangitis and cirrhosis avoid getting worse and needing a liver transplant or facing death.
Related topics
Quick answers
How many Primary Biliary Cholangitis (PBC) clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 29 countries. The most sites are in China (5 trials), Spain (4 trials), Argentina (1 trial), Australia (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.